143 related articles for article (PubMed ID: 35158994)
1. Glioblastoma Cells Counteract PARP Inhibition through Pro-Survival Induction of Lipid Droplets Synthesis and Utilization.
Majuelos-Melguizo J; Rodríguez-Vargas JM; Martínez-López N; Delgado-Bellido D; García-Díaz Á; Yuste VJ; García-Macía M; López LM; Singh R; Oliver FJ
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158994
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide.
Tentori L; Ricci-Vitiani L; Muzi A; Ciccarone F; Pelacchi F; Calabrese R; Runci D; Pallini R; Caiafa P; Graziani G
BMC Cancer; 2014 Mar; 14():151. PubMed ID: 24593254
[TBL] [Abstract][Full Text] [Related]
3. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.
Balvers RK; Lamfers ML; Kloezeman JJ; Kleijn A; Berghauser Pont LM; Dirven CM; Leenstra S
J Transl Med; 2015 Feb; 13():74. PubMed ID: 25886061
[TBL] [Abstract][Full Text] [Related]
4. Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair.
Higuchi F; Nagashima H; Ning J; Koerner MVA; Wakimoto H; Cahill DP
Clin Cancer Res; 2020 Apr; 26(7):1690-1699. PubMed ID: 31900275
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.
Gariani K; Ryu D; Menzies KJ; Yi HS; Stein S; Zhang H; Perino A; Lemos V; Katsyuba E; Jha P; Vijgen S; Rubbia-Brandt L; Kim YK; Kim JT; Kim KS; Shong M; Schoonjans K; Auwerx J
J Hepatol; 2017 Jan; 66(1):132-141. PubMed ID: 27663419
[TBL] [Abstract][Full Text] [Related]
6. Assessing fatty acid-induced lipotoxicity and its therapeutic potential in glioblastoma using stimulated Raman microscopy.
Yuan Y; Shah N; Almohaisin MI; Saha S; Lu F
Sci Rep; 2021 Apr; 11(1):7422. PubMed ID: 33795756
[TBL] [Abstract][Full Text] [Related]
7. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma.
Majuelos-Melguizo J; Rodríguez MI; López-Jiménez L; Rodríguez-Vargas JM; Martí Martín-Consuegra JM; Serrano-Sáenz S; Gavard J; de Almodóvar JM; Oliver FJ
Oncotarget; 2015 Mar; 6(7):4790-803. PubMed ID: 25576921
[TBL] [Abstract][Full Text] [Related]
8. PARP-1-Targeted Radiotherapy in Mouse Models of Glioblastoma.
Jannetti SA; Carlucci G; Carney B; Kossatz S; Shenker L; Carter LM; Salinas B; Brand C; Sadique A; Donabedian PL; Cunanan KM; Gönen M; Ponomarev V; Zeglis BM; Souweidane MM; Lewis JS; Weber WA; Humm JL; Reiner T
J Nucl Med; 2018 Aug; 59(8):1225-1233. PubMed ID: 29572254
[TBL] [Abstract][Full Text] [Related]
9. Lipid Droplets Maintain Energy Homeostasis and Glioblastoma Growth via Autophagic Release of Stored Fatty Acids.
Wu X; Geng F; Cheng X; Guo Q; Zhong Y; Cloughesy TF; Yong WH; Chakravarti A; Guo D
iScience; 2020 Oct; 23(10):101569. PubMed ID: 33083736
[TBL] [Abstract][Full Text] [Related]
10. PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.
Karpel-Massler G; Pareja F; Aimé P; Shu C; Chau L; Westhoff MA; Halatsch ME; Crary JF; Canoll P; Siegelin MD
PLoS One; 2014; 9(12):e114583. PubMed ID: 25531448
[TBL] [Abstract][Full Text] [Related]
11. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD
J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells.
Venere M; Hamerlik P; Wu Q; Rasmussen RD; Song LA; Vasanji A; Tenley N; Flavahan WA; Hjelmeland AB; Bartek J; Rich JN
Cell Death Differ; 2014 Feb; 21(2):258-69. PubMed ID: 24121277
[TBL] [Abstract][Full Text] [Related]
13. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors.
Golden EB; Cho HY; Hofman FM; Louie SG; Schönthal AH; Chen TC
Neurosurg Focus; 2015 Mar; 38(3):E12. PubMed ID: 25727221
[TBL] [Abstract][Full Text] [Related]
14. Oleic acid-induced defective autolysosome shows impaired lipid degradation.
Lee DH; Ahn J; Jang YJ; Ha TY; Jung CH
Biochem Biophys Res Commun; 2019 Jun; 513(3):553-559. PubMed ID: 30981498
[TBL] [Abstract][Full Text] [Related]
15. Acquired resistance of phosphatase and tensin homolog-deficient cells to poly(ADP-ribose) polymerase inhibitor and Ara-C mediated by 53BP1 loss and SAMHD1 overexpression.
Wang YT; Yuan B; Chen HD; Xu L; Tian YN; Zhang A; He JX; Miao ZH
Cancer Sci; 2018 Mar; 109(3):821-831. PubMed ID: 29274141
[TBL] [Abstract][Full Text] [Related]
16. PARP-1 protein expression in glioblastoma multiforme.
Galia A; Calogero AE; Condorelli R; Fraggetta F; La Corte A; Ridolfo F; Bosco P; Castiglione R; Salemi M
Eur J Histochem; 2012 Feb; 56(1):e9. PubMed ID: 22472897
[TBL] [Abstract][Full Text] [Related]
17. PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity.
Gupta SK; Smith EJ; Mladek AC; Tian S; Decker PA; Kizilbash SH; Kitange GJ; Sarkaria JN
Front Oncol; 2018; 8():670. PubMed ID: 30723695
[TBL] [Abstract][Full Text] [Related]
18. Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
Lesueur P; Lequesne J; Grellard JM; Dugué A; Coquan E; Brachet PE; Geffrelot J; Kao W; Emery E; Berro DH; Castera L; Goardon N; Lacroix J; Lange M; Capel A; Leconte A; Andre B; Léger A; Lelaidier A; Clarisse B; Stefan D
BMC Cancer; 2019 Mar; 19(1):198. PubMed ID: 30832617
[TBL] [Abstract][Full Text] [Related]
19. Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90.
Dungey FA; Caldecott KW; Chalmers AJ
Mol Cancer Ther; 2009 Aug; 8(8):2243-54. PubMed ID: 19671736
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
Geng F; Cheng X; Wu X; Yoo JY; Cheng C; Guo JY; Mo X; Ru P; Hurwitz B; Kim SH; Otero J; Puduvalli V; Lefai E; Ma J; Nakano I; Horbinski C; Kaur B; Chakravarti A; Guo D
Clin Cancer Res; 2016 Nov; 22(21):5337-5348. PubMed ID: 27281560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]